Corporate
Jun. 6, 2013
San Diego drugmaker appoints first GC
San Diego-based biopharmaceutical company Trius Therapeutics Inc. has named an industry veteran as its first general counsel as the company prepares to shepherd its primary drug candidate from development to market.
Daily Journal Staff Writer
As San Diego-based biopharmaceutical company Trius Therapeutics Inc. prepares to move its primary drug candidate from development to commercialization, the company has brought on an industry veteran as its first general counsel, the company announced this week.
Matthew W. Onaitis brings broad legal experience from both development-stage and commercial-stage pharmaceutical companies, Trius President...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In